State Medicaid DUR Board Meeting - Revision 10
This is a Notice Revision
You are currently viewing a revision of a notice. This is a previous copy of a notice that has been published more recently. To view the current version of this notice, click here.
Please Note: Only the files that were associated to this version are included in the Download Attachments section. If that section does not display, all attachments were removed from this version of the notice.
General Information
- Government Type
- State Agency
- Entity
- Department of Health and Human Services (DHHS)
- Public Body
- Drug Utilization Review Board
Notice Information
- Notice Title
- State Medicaid DUR Board Meeting
- Notice Tags
- Medicaid, Pharmacies
- Notice Type(s)
- Meeting
- Event Start Date & Time
- April 10, 2025 07:15 AM
- Event End Date & Time
- April 10, 2025 08:30 AM
- Event Deadline Date & Time
- 04/10/25 08:30 AM
- Description/Agenda
- Drug Utilization Review Board Meeting Agenda Thursday, April 10, 2025 7:15 am to 8:30 am Google Meet Joining Info Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306# Persons who wish to address the DUR Board may contact Ngan Huynh at (nganhuynh@utah.gov) prior to the meeting, or sign up to provide comments at the meeting. Public comments will be limited to 3 minutes per speaker or organization due to time constraints. 1) Call to order- Sharon M. Weinstein, MD a) Welcome and Introductions - Sharon M. Weinstein, MD Housekeeping Staff Update - Sepideh Daeery, PharmD b) Review and Approval of Minutes - Sharon M. Weinstein, MD 2) P&T Update - Ngan Huynh, PharmD 3) Review a) Alyftrek & Other CTFF Modulators for Cystic Fibrosis Review - Lauren Heath, PharmD i) Public Comment (1) Vertex: Alyftrek - Taha Khan, PharmD (2) Alyftrek testimonial - Stacey Allen (3) Alyftrek testimonial - Makinnon Baugh (4) Alyftrek testimonial - Amy Baugh (5) Eli Lilly: Zepbound - Beth Lubelcyzk, PharmD i) Committee Discussion/Questions ii) Committee Action b) CF Modulators Prior Authorization - Ngan Huynh, PharmD i) Committee Discussion/Questions ii) Committee Action c) Skyclarys (omaveloxolone) Prior Authorization - Luis Moreno, PharmD i) Committee Discussion/Questions d) Zepbound - (tirzepatide) -Ashley Park, PharmD i) Committee Discussion/Questions ii) Committee Action 4) Next Meeting a) May 8, 2025 - Alhemo for Hemophilia and Zyntego Prior Authorization 5) Adjourned
- Notice of Special Accommodations (ADA)
- In compliance with the Americans with Disabilities Act, individuals needing special accommodations (including auxiliary communicative aids and services) during this meeting should notify Luis Moreno at 801-538-6155.
- Notice of Electronic or Telephone Participation
- Video call link: meet.google.com/zue-rrqz-rpb Or dial: (US) +1 904-900-0180 PIN: 172 873 306#
Meeting Information
- Meeting Location
-
Video/Teleconferencing
Video/Teleconferencing, UT 84116
Show in Apple Maps Show in Google Maps - Contact Name
- Luis Moreno
- Contact Email
- lmoreno@utah.gov
- Contact Phone
- 801-538-6155
Notice Posting Details
- Notice Posted On
- March 27, 2025 08:11 PM
- Notice Last Edited On
- April 08, 2025 12:37 PM
- Deadline Date
- April 10, 2025 08:30 AM